Incidence and antimicrobial susceptibility of Escherichia coli and Klebsiella pneumoniae with extended-spectrum beta-lactamases in community- and hospital-associated intra-abdominal infections in Europe: results of the 2008 Study for Monitoring Anti
about
Antimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA).Complicated intra-abdominal infections worldwide: the definitive data of the CIAOW Study.Trends in susceptibility of Escherichia coli from intra-abdominal infections to ertapenem and comparators in the United States according to data from the SMART program, 2009 to 2013Dominance of CTX-M-type extended-spectrum β-lactamase (ESBL)-producing Escherichia coli isolated from patients with community-onset and hospital-onset infection in China.Cost of care and antibiotic prescribing attitudes for community-acquired complicated intra-abdominal infections in Italy: a retrospective study.2013 WSES guidelines for management of intra-abdominal infections.WSES consensus conference: Guidelines for first-line management of intra-abdominal infections.Whole genome sequence analysis of the first Australian OXA-48-producing outbreak-associated Klebsiella pneumoniae isolates: the resistome and in vivo evolution.Clinical importance and epidemiology of quinolone resistance.Identifying patients harboring extended-spectrum-beta-lactamase-producing Enterobacteriaceae on hospital admission: derivation and validation of a scoring systemSusceptibility of Klebsiella pneumoniae isolates from intra-abdominal infections and molecular characterization of ertapenem-resistant isolatesRelationship between Antimicrobial Consumption and the Incidence of Antimicrobial Resistance in Escherichia coli and Klebsiella pneumoniae Isolates.Non-phenotypic tests to detect and characterize antibiotic resistance mechanisms in Enterobacteriaceae.Trends in Expanded-Spectrum Cephalosporin-Resistant Escherichia coli and Klebsiella pneumoniae among Dutch Clinical Isolates, from 2008 to 2012Global fluoroquinolone resistance epidemiology and implictions for clinical use.Utility of a clinical risk factor scoring model in predicting infection with extended-spectrum β-lactamase-producing enterobacteriaceae on hospital admission.Phase I Study Assessing the Pharmacokinetic Profile, Safety, and Tolerability of a Single Dose of Ceftazidime-Avibactam in Hospitalized Pediatric Patients.Third-generation cephalosporin resistance of community-onset Escherichia coli and Klebsiella pneumoniae bacteremia in a secondary hospital.Recent developments in antibiotic agents for the treatment of complicated intra-abdominal infections.Trending eight years of in vitro activity of ertapenem and comparators against Escherichia coli from intra-abdominal infections in North America--SMART 2002-2009.Predicting Multidrug-Resistant Gram-Negative Bacterial Colonization and Associated Infection on Hospital Admission.Epidemiology and Antimicrobial Susceptibility of Gram-Negative Pathogens Causing Intra-abdominal Infections in Pediatric Patients in Europe-SMART 2011-2014.Prevalence and Risk Factors for Colonization With Extended-Spectrum Cephalosporin-Resistant Escherichia coli in Children Attending Daycare Centers: A Cohort Study in the Netherlands.Comparative study of the efficacy and safety of ceftazidime/avibactam plus metronidazole versus meropenem in the treatment of complicated intra-abdominal infections in hospitalized adults: results of a randomized, double-blind, Phase II trial.Antimicrobial management of intra-abdominal infections: literature's guidelines.Epidemiology and antimicrobial susceptibility of Gram-negative aerobic bacteria causing intra-abdominal infections during 2010-2011.Mechanisms and fitness costs of tigecycline resistance in Escherichia coli.Risk factors for hospital-acquired bloodstream infections caused by extended-spectrum β-lactamase Klebsiella pneumoniae among cancer patients.
P2860
Q26739860-B56646B9-3985-4C1A-AED6-3C606F400F33Q30828046-8F092055-EE81-45BE-87CD-91D441B208E7Q30914624-C8F99453-377B-48C7-9487-E32F80B977DBQ33830187-0F09F754-8B25-4543-A503-2C303B7749FBQ33904115-E631DAD0-8475-42FC-B0C4-34244B4F3A3CQ34321150-6B62456B-B005-4322-976F-32A2BF301C38Q34541183-B0B4B288-F775-4EFF-8AB8-7CFE0B997D31Q34652593-4CBBBBA9-B0D8-4D22-B6F5-7624D7168936Q34838791-BD02505A-6E76-44D2-8632-EDCB90CC58FBQ35065875-0F4F8B73-9801-43D4-8C5E-72CF90C618B9Q35139440-F5EE0FFA-5DDB-45AD-9BB5-7C976AC3F41FQ35230461-DED9A873-326A-4A2C-91F3-552D3CEE1D54Q35297743-48DAD325-DBAD-4ED9-94B7-8EAE574A82A6Q35779627-3EAA4EA7-A31E-4010-AE99-CE480A52A043Q36337074-7DD00759-C6BB-42E9-9E02-EC7E8218772BQ36810340-6E49D6AC-5393-418B-8F15-1BB606C7CC19Q37287753-85D5F968-783C-4526-BA83-0CAF0D406E83Q37598820-B99338A1-57C3-48DF-BF7C-B1314F530392Q38648594-EB452A52-D178-4B16-86C6-945520126F75Q39696548-F541A5DC-94B5-4345-BFC2-5C3CBA72E322Q40067652-063D2F77-32FE-48D3-A8F5-839A55940EF4Q40789108-D127A4F4-B86F-435B-AC0D-3D61D3A3D25FQ40981679-08A4ED84-4C15-4548-B98E-DA297F69FE96Q42275878-18BC7D36-70AB-48EC-A416-ED3A4FD1B80AQ42592661-A30E0F12-70C4-4898-9E77-2F9CEE84EACAQ45974148-9651F0AA-F7C8-4C7B-87E5-1F4CD9668907Q54307659-5F92166E-D8BE-43A4-BE42-65ED0A3178F0Q54508230-277F21CA-5453-4A6F-8710-60BA57D73A6A
P2860
Incidence and antimicrobial susceptibility of Escherichia coli and Klebsiella pneumoniae with extended-spectrum beta-lactamases in community- and hospital-associated intra-abdominal infections in Europe: results of the 2008 Study for Monitoring Anti
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Incidence and antimicrobial su ...... 2008 Study for Monitoring Anti
@en
Incidence and antimicrobial su ...... 2008 Study for Monitoring Anti
@nl
type
label
Incidence and antimicrobial su ...... 2008 Study for Monitoring Anti
@en
Incidence and antimicrobial su ...... 2008 Study for Monitoring Anti
@nl
prefLabel
Incidence and antimicrobial su ...... 2008 Study for Monitoring Anti
@en
Incidence and antimicrobial su ...... 2008 Study for Monitoring Anti
@nl
P2093
P2860
P356
P1476
Incidence and antimicrobial su ...... 2008 Study for Monitoring Anti
@en
P2093
Daryl J Hoban
Fernando Baquero
Rafael Cantón
Robert E Badal
Samuel K Bouchillon
Stephen P Hawser
P2860
P304
P356
10.1128/AAC.00265-10
P407
P577
2010-04-26T00:00:00Z